Cure Alzheimer's Fund

Cure Alzheimer's Fund
Founded 2004
Type Foundation
Focus Alzheimer's disease research
Location
  • Wellesley Hills, Massachusetts
President and CEO
 Timothy W. Armour[1]
Website curealz.org

Cure Alzheimer’s Fund (CAF) is a non-profit organization[2][3] based in Wellesley, Massachusetts. It supports and funds research focusing on understanding and potentially curing Alzheimer's disease utilizing a venture philanthropy approach, targeting research with the highest probability of preventing, slowing or reversing Alzheimer's disease.[4]

History and background

Cure Alzheimer’s Fund was founded in 2004 by Jeffrey Morby, Jacqui Morby, Henry McCance, and Phyllis Rappaport as a way to fund research of Alzheimer's disease. As a non-profit, Cure Alzheimer's Fund provides grants to the world's leading researchers.[5] The Board of Directors covers all operating costs so that 100% of all donations go directly to research. As of 2017, the Fund has provided over 300 research grants totaling just over $67 million. [6]

Events

Symposium

Researcher Rudolph Tanzi, Ph. D., at the 2012 Symposium

Cure Alzheimer's Fund hosts an annual fall symposium in which funded researchers present their recent work. The event is held in Boston, free and open to the public. Recent presenters include Rudy Tanzi, Ph.D., Sam Gandy, M.D., Ph.D., and Steven Wagner, Ph.D.

Alzstream™

Alzstream™ is a livestreamed webinar series, presented every quarter. The Alzstream webinars focus on discussing Alzheimer's research discoveries, progress, and new theories regarding Alzheimer's disease, featuring many members of the Research Consortium and others.

Funded research programs

Cure Alzheimer’s Fund’s Research Roadmap

Cure Alzheimer’s Fund’s research objective is to support studies that will bring forward a further understanding of Alzheimer's disease and/or a development of treatment.

All projects are based upon Cure Alzheimer’s roadmap of discovery, developed by the Research Consortium. Projects are then approved by the Scientific Advisory Board (hyperlinked) and the Executive Committee of the Board of Directors. This roadmap includes four steps needed to develop effective therapies: foundational genetics, translational research, drug discovery, and drug development.

Alzheimer's Genome Project

The Alzheimer’s Genome Project™[7] (AGP) is one of CAF’s longest continued projects, with approximately $9,041,400 in funding from 2005 to 2013 for research directed by Rudolph Tanzi, Ph.D., of Harvard Medical School and Massachusetts General Hospital.[8] Its objective is to evaluate new Alzheimer's disease gene candidates for effects on Alzheimer’s pathology and related biological pathways.[9] Phase I of the AGP focused on identifying all genes that contribute significant risk for Alzheimer's disease, thereby identifying more targets for the development of therapeutic interventions. Phase I was completed in 2008, with the identification of the novel Alzheimer’s genes ADAM10, ATXN1, and CD33. Phase II of the AGP entails the functional analysis of these genes.

Phase III of the AGP focuses on the processing and sequencing of the complete genomes, then identifying all DNA variants in the genome that directly influence risk of Alzheimer's disease. From there, all of the biologically relevant genomes that may cause Alzheimer’s can be identified and targeted for the development of therapeutic treatments. The Alzheimer’s Genome Project was the largest single disease scan of all time and was considered one of the top ten medical breakthroughs in the world in 2008 by Time Magazine.[10]

References

  1. ↑ "Message from the Chairman". Cure Alzheimer's Fund. Retrieved July 24, 2015.
  2. ↑ GuideStar. . Accessed 26 March 2014.
  3. ↑ Better Business Bureau. . Accessed 26 March 2014.
  4. ↑ Charity Navigator. . Accessed 5 March 2014.
  5. ↑ Huffington Post. Can the VC Model Help Cure Alzheimer's?. Accessed 26 March 2014.
  6. ↑ Cure Alzheimer's Fund. . Accessed 5 March 2014.
  7. ↑ Cure Alzheimer's Fund. . Accessed March 5, 2014.
  8. ↑ Mass General Hospital. . Accessed 26 March 2014.
  9. ↑ Boston Business Journal. . Accessed 26 March 2014.
  10. ↑ Time. . Accessed 5 March 2014.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.